List of Tables
    Table 1. Endocrine Therapy Drugs for Breast Cancer Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Endocrine Therapy Drugs for Breast Cancer Market Trends
    Table 3. Endocrine Therapy Drugs for Breast Cancer Market Drivers
    Table 4. Endocrine Therapy Drugs for Breast Cancer Market Challenges
    Table 5. Endocrine Therapy Drugs for Breast Cancer Market Restraints
    Table 6. Global Endocrine Therapy Drugs for Breast Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Endocrine Therapy Drugs for Breast Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Endocrine Therapy Drugs for Breast Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Endocrine Therapy Drugs for Breast Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Endocrine Therapy Drugs for Breast Cancer Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Endocrine Therapy Drugs for Breast Cancer Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Player, 2017-2022
    Table 13. Global Endocrine Therapy Drugs for Breast Cancer Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Endocrine Therapy Drugs for Breast Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Therapy Drugs for Breast Cancer as of 2021)
    Table 15. Top Players of Endocrine Therapy Drugs for Breast Cancer in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Endocrine Therapy Drugs for Breast Cancer Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Endocrine Therapy Drugs for Breast Cancer Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Endocrine Therapy Drugs for Breast Cancer Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Endocrine Therapy Drugs for Breast Cancer Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Endocrine Therapy Drugs for Breast Cancer Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Endocrine Therapy Drugs for Breast Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Endocrine Therapy Drugs for Breast Cancer Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Endocrine Therapy Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Endocrine Therapy Drugs for Breast Cancer Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Endocrine Therapy Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Endocrine Therapy Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Teva Company Details
    Table 31. Teva Business Overview
    Table 32. Teva Endocrine Therapy Drugs for Breast Cancer Product
    Table 33. Teva Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 34. Teva Recent Development
    Table 35. Amneal Pharms Company Details
    Table 36. Amneal Pharms Business Overview
    Table 37. Amneal Pharms Endocrine Therapy Drugs for Breast Cancer Product
    Table 38. Amneal Pharms Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 39. Amneal Pharms Recent Development
    Table 40. AstraZeneca Company Details
    Table 41. AstraZeneca Business Overview
    Table 42. AstraZeneca Endocrine Therapy Drugs for Breast Cancer Product
    Table 43. AstraZeneca Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 44. AstraZeneca Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis Endocrine Therapy Drugs for Breast Cancer Product
    Table 48. Novartis Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. Intas Pharmaceuticals Company Details
    Table 51. Intas Pharmaceuticals Business Overview
    Table 52. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product
    Table 53. Intas Pharmaceuticals Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 54. Intas Pharmaceuticals Recent Development
    Table 55. Chemo Company Details
    Table 56. Chemo Business Overview
    Table 57. Chemo Endocrine Therapy Drugs for Breast Cancer Product
    Table 58. Chemo Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 59. Chemo Recent Development
    Table 60. Accure Labs Company Details
    Table 61. Accure Labs Business Overview
    Table 62. Accure Labs Endocrine Therapy Drugs for Breast Cancer Product
    Table 63. Accure Labs Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 64. Accure Labs Recent Development
    Table 65. Natco Company Details
    Table 66. Natco Business Overview
    Table 67. Natco Endocrine Therapy Drugs for Breast Cancer Product
    Table 68. Natco Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 69. Natco Recent Development
    Table 70. Zydus Pharmaceuticals Company Details
    Table 71. Zydus Pharmaceuticals Business Overview
    Table 72. Zydus Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product
    Table 73. Zydus Pharmaceuticals Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 74. Zydus Pharmaceuticals Recent Development
    Table 75. Sanofi Company Details
    Table 76. Sanofi Business Overview
    Table 77. Sanofi Endocrine Therapy Drugs for Breast Cancer Product
    Table 78. Sanofi Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 79. Sanofi Recent Development
    Table 80. Pfizer Company Details
    Table 81. Pfizer Business Overview
    Table 82. Pfizer Endocrine Therapy Drugs for Breast Cancer Product
    Table 83. Pfizer Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 84. Pfizer Recent Development
    Table 85. Mylan  Company Details
    Table 86. Mylan  Business Overview
    Table 87. Mylan  Endocrine Therapy Drugs for Breast Cancer Product
    Table 88. Mylan  Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 89. Mylan  Recent Development
    Table 90. Wockhardt Company Details
    Table 91. Wockhardt Business Overview
    Table 92. Wockhardt Endocrine Therapy Drugs for Breast Cancer Product
    Table 93. Wockhardt Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 94. Wockhardt Recent Development
    Table 95. Cipla Company Details
    Table 96. Cipla Business Overview
    Table 97. Cipla Endocrine Therapy Drugs for Breast Cancer Product
    Table 98. Cipla Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 99. Cipla Recent Development
    Table 100. Actiza Pharmaceutical Company Details
    Table 101. Actiza Pharmaceutical Business Overview
    Table 102. Actiza Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Product
    Table 103. Actiza Pharmaceutical Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 104. Actiza Pharmaceutical Recent Development
    Table 105. Hikma Pharmaceuticals Company Details
    Table 106. Hikma Pharmaceuticals Business Overview
    Table 107. Hikma Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product
    Table 108. Hikma Pharmaceuticals Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 109. Hikma Pharmaceuticals Recent Development
    Table 110. Shanghai Forward Technology Company Details
    Table 111. Shanghai Forward Technology Business Overview
    Table 112. Shanghai Forward Technology Endocrine Therapy Drugs for Breast Cancer Product
    Table 113. Shanghai Forward Technology Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 114. Shanghai Forward Technology Recent Development
    Table 115. Bayer Company Details
    Table 116. Bayer Business Overview
    Table 117. Bayer Endocrine Therapy Drugs for Breast Cancer Product
    Table 118. Bayer Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 119. Bayer Recent Development
    Table 120. Liaoning Kangtai Pharmaceutical Company Details
    Table 121. Liaoning Kangtai Pharmaceutical Business Overview
    Table 122. Liaoning Kangtai Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Product
    Table 123. Liaoning Kangtai Pharmaceutical Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 124. Liaoning Kangtai Pharmaceutical Recent Development
    Table 125. Fu 'an Pharmaceutical Group Company Details
    Table 126. Fu 'an Pharmaceutical Group Business Overview
    Table 127. Fu 'an Pharmaceutical Group Endocrine Therapy Drugs for Breast Cancer Product
    Table 128. Fu 'an Pharmaceutical Group Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 129. Fu 'an Pharmaceutical Group Recent Development
    Table 130. Apotex Company Details
    Table 131. Apotex Business Overview
    Table 132. Apotex Endocrine Therapy Drugs for Breast Cancer Product
    Table 133. Apotex Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 134. Apotex Recent Development
    Table 135. Taro Company Details
    Table 136. Taro Business Overview
    Table 137. Taro Endocrine Therapy Drugs for Breast Cancer Product
    Table 138. Taro Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 139. Taro Recent Development
    Table 140. Sun Phamaceutical Company Details
    Table 141. Sun Phamaceutical Business Overview
    Table 142. Sun Phamaceutical Endocrine Therapy Drugs for Breast Cancer Product
    Table 143. Sun Phamaceutical Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 144. Sun Phamaceutical Recent Development
    Table 145. Intas Pharmaceuticals Company Details
    Table 146. Intas Pharmaceuticals Business Overview
    Table 147. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product
    Table 148. Intas Pharmaceuticals Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 149. Intas Pharmaceuticals Recent Development
    Table 150. Chemo Company Details
    Table 151. Chemo Business Overview
    Table 152. Chemo Endocrine Therapy Drugs for Breast Cancer Product
    Table 153. Chemo Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 154. Chemo Recent Development
    Table 155. Accure Labs Company Details
    Table 156. Accure Labs Business Overview
    Table 157. Accure Labs Endocrine Therapy Drugs for Breast Cancer Product
    Table 158. Accure Labs Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 159. Accure Labs Recent Development
    Table 160. Sun Pharmaceutical Company Details
    Table 161. Sun Pharmaceutical Business Overview
    Table 162. Sun Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Product
    Table 163. Sun Pharmaceutical Revenue in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 164. Sun Pharmaceutical Recent Development
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Endocrine Therapy Drugs for Breast Cancer Product Picture
    Figure 2. Global Endocrine Therapy Drugs for Breast Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Endocrine Therapy Drugs for Breast Cancer Market Size 2017-2028 (US$ Million)
    Figure 4. United States Endocrine Therapy Drugs for Breast Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Endocrine Therapy Drugs for Breast Cancer Market Size 2017-2028 (US$ Million)
    Figure 6. United States Endocrine Therapy Drugs for Breast Cancer Market Share in Global 2017-2028
    Figure 7. Endocrine Therapy Drugs for Breast Cancer Report Years Considered
    Figure 8. Product Picture of Tamoxifen
    Figure 9. Product Picture of Anastrozole
    Figure 10. Product Picture of Exemestane
    Figure 11. Product Picture of Letrozole
    Figure 12. Product Picture of Goserelin
    Figure 13. Product Picture of Fulvestrant
    Figure 14. Global Endocrine Therapy Drugs for Breast Cancer Market Share by Type in 2022 & 2028
    Figure 15. Global Endocrine Therapy Drugs for Breast Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Endocrine Therapy Drugs for Breast Cancer Market Share by Type (2017-2028)
    Figure 17. United States Endocrine Therapy Drugs for Breast Cancer Market Share by Type in 2022 & 2028
    Figure 18. United States Endocrine Therapy Drugs for Breast Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Endocrine Therapy Drugs for Breast Cancer Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Drug Center
    Figure 23. Product Picture of Other
    Figure 24. Global Endocrine Therapy Drugs for Breast Cancer Market Share by Application in 2022 & 2028
    Figure 25. Global Endocrine Therapy Drugs for Breast Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Endocrine Therapy Drugs for Breast Cancer Market Share by Application (2017-2028)
    Figure 27. United States Endocrine Therapy Drugs for Breast Cancer Market Share by Application in 2022 & 2028
    Figure 28. United States Endocrine Therapy Drugs for Breast Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Endocrine Therapy Drugs for Breast Cancer Market Share by Application (2017-2028)
    Figure 30. North America Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E Endocrine Therapy Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Teva Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 59. Amneal Pharms Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 60. AstraZeneca Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 62. Intas Pharmaceuticals Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 63. Chemo Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 64. Accure Labs Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 65. Natco Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 66. Zydus Pharmaceuticals Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 67. Sanofi Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 68. Pfizer Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 69. Mylan  Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 70. Wockhardt Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 71. Cipla Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 72. Actiza Pharmaceutical Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 73. Hikma Pharmaceuticals Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 74. Shanghai Forward Technology Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 75. Bayer Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 76. Liaoning Kangtai Pharmaceutical Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 77. Fu 'an Pharmaceutical Group Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 78. Apotex Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 79. Taro Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 80. Sun Phamaceutical Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 81. Intas Pharmaceuticals Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 82. Chemo Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 83. Accure Labs Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 84. Sun Pharmaceutical Revenue Growth Rate in Endocrine Therapy Drugs for Breast Cancer Business (2017-2022)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed